C.V. Support Formula™
Aid for cardiovascular health
DESCRIPTION
C.V. Support Formula™, provided by Douglas Laboratories, is a synergistic and comprehensive combination of vitamins, minerals, enzymes, herbals, and other nutrients, carefully formulated and specifically designed to support the healthy structure and function of the cardiovascular system.
FUNCTIONS
Studies show that a high percentage of adults in North America and other developed countries eat less than the minimum daily allowance of 10 or more essential nutrients. Adequate amounts and proper balance of these nutrients are needed not only for maintaining good health, but also for the dietary management of the body’s structure as well as the optimum functioning of its various systems, including the cardiovascular system. C.V. Support Formula™ has been carefully developed to contain the right proportions of vitamins, minerals, trace elements, and other nutrients without danger of toxic build-up or of side effects. Each ingredient is selected in consideration of its absorbability, competitive relationship with other nutrients, allergenic potential, and long-term safety. Certain nutrients such as beta-carotene, vitamin C, vitamin E and B-complex vitamins are included in high-potency amounts because of the vital roles they play in antioxidant protection, energy production and maintenance of healthy blood cells, nervous system, hormonal balance, and more. Minerals and trace elements are provided in their safest and most bioavailable forms.
C.V. Support Formula™ contains not only the base formula of Douglas Laboratories’ Ultra-Specific Nutrition 2000 Series™ that offers intensive support for the healthy functioning of the body in general including the heart and vascular system, but also a blend of herbs and additional nutrients specifically formulated for maintenance of healthy cardiovascular structure and function. Herbs such as hawthorn and ginkgo have vasodilatory effects on the cardiovascular system, lowering the resistance to blood flow in the peripheral vascular system. Other positive actions on cardiovascular structure and function include inotropic effects, increasing heart rate, contractile force, and nerve conductivity. C.V. Support FormulaÔ also provides potent antioxidant protection against free radical-induced oxidative damage to the cardiovascular system.
INDICATIONS
C.V. Support FormulaÔ may be a useful dietary supplement for those who wish to support the healthy structure and function of their cardiovascular system.
FORMULA (#4550)
Four Tablets Contain:
500 mg CV-Support Proprietary Blend of:
EDTA, Lecithin (Soya, yielding Phosphatidylcholine, Phosphatidylethanolamine and Phosphatidylinositol), Mucopolysaccharides, Polysaccharides, Betaine HCl, , L-Carnitine, Garlic (deodorized), Pepsin, Papain, Trypsin, Chymotrypsin, Cayenne, Chickweed, Hawthorn Berry, Pectin, Mistletoe, Alfalfa (leaf), Ginger, L-Cysteine/N-Acetyl-L-Cysteine, , L-Methionine, Bromelain (minimum 2000 m.c.u.), Coenzyme Q-10/Ubiquinone, Ginkgo biloba, Pantethine and Glutamic Acid HCl
Beta-Carotene (Vitamin A Activity)....... 15,000.. I.U.
Vitamin A (Palmitate, Water Dispersible) 5,000.. I.U.
Vitamin D-3......................................................... 50.. I.U.
Vitamin E (Succinate)..................................... 200.. I.U.
Vitamin C (Ascorbic Acid).......................... 1,000.. mg
Vitamin B-1 (Thiamine HCl)........................... 50.. mg
Vitamin B-2 (Riboflavin).................................. 25.. mg
Niacin................................................................... 20.. mg
Niacinamide...................................................... 100.. mg
Pantothenic Acid (as d-Calcium Pantothenate) 200 mg
Vitamin B-6......................................................... 25.. mg
(as Pyridoxine HCl/Pyridoxal-5-Phosphate Complex)
Vitamin B-12.................................................... 100.. mcg
Folic Acid........................................................... 800.. mcg
Biotin.................................................................. 300.. mcg
Choline(from Choline Citrate/Bitartrate)...... 20.. mg
Inositol................................................................. 25.. mg
Citrus Bioflavonoid Complex....................... 100.. mg
PABA (Para-Aminobenzoic Acid)................... 50.. mg
Calcium (Citrate/Ascorbate Complex)........ 300.. mg
Magnesium....................................................... 300.. mg
(Aspartate/Ascorbate Complex)
Potassium (Aspartate Complex)..................... 75.. mg
Zinc (Aspartate Complex)................................ 20.. mg
Copper (Amino Acid Chelate)............................ 2.. mg
Manganese (Aspartate Complex)................... 15.. mg
Chromium GTF................................................ 200.. mcg
(Organically bound with GTF activity-low allergenicity)
Selenium............................................................ 200.. mcg
(Organic Selenium in Krebs† Cycle and Kelp)
Molybdenum (Krebs†)....................................... 50.. mcg
Vanadium (Krebs†)............................................ 25.. mcg
Boron (Aspartate/Citrate Complex)................. 1.. mg
Trace Elements (Sea Vegetation).................. 100.. mcg
†Krebs=Citrate, Fumarate, Malate, Glutarate and Succinate Complex
SUGGESTED USE
Adults take 4 tablets daily with meals or as directed by physician.
SIDE EFFECTS
No adverse effects have been reported
STORAGE
Store in a cool, dry place, away from direct light. Keep out of reach of children.
References
Charleux JL. Beta-carotene, vitamin C, and vitamin E: the protective micronutrients. Nutr Rev 1996;54:S109-14.
Cooke JP. Nutriceuticals [sic] for cardiovascular health. Am J Cardiol 1998;82:43S-46S.
Craig WJ. Phytochemicals: guardians of our health. J Am Diet Assoc 1997;97:S199-204.
Craig WJ. Health-promoting properties of common herbs. Am J Clin Nutr 1999;70:491S-499S.
Emmert DH, Kirchner JT. The role of vitamin E in the prevention of heart disease. Arch Fam Med 1999;8:537-42.
Kendler BS. Recent nutritional approaches to the prevention and therapy of cardiovascular disease. Prog Cardiovasc Nurs 1997;12:3-23.
Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87:897-904.
Langsjoen PH, Langsjoen AM. Overview of the use of CoQ10 in cardiovascular disease. Biofactors 1999;9:273-84.
Leader S, Mallick R. Tapping the savings from vitamin-based prevention. Manag Care Interface 1998;11:95-9.
Nagel E, Meyer zu Vilsendorf A, Bartels M, Pichlmayr R. Antioxidative vitamins in prevention of ischemia/reperfusion injury. Int J Vitam Nutr Res 1997;67:298-306.
Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S. Coenzyme Q10 in health and disease. Eur J Clin Nutr 1999;53:764-70.
Wood JL, Allison RG. Effects of consumption of choline and lecithin on neurological and cardiovascular systems. Fed Proc 1982;41:3015-21